Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.

Tsuda H, Su CA, Tanaka T, Ayasoufi K, Min B, Valujskikh A, Fairchild RL.

JCI Insight. 2018 Feb 22;3(4). pii: 96940. doi: 10.1172/jci.insight.96940. [Epub ahead of print]

PMID:
29467328
2.

Inflammatory Cytokines in the Papillary Tips and Urine of Nephrolithiasis Patients.

Sun AY, Hinck B, Cohen BR, Keslar K, Fairchild RL, Monga M.

J Endourol. 2018 Jan 16. doi: 10.1089/end.2017.0699. [Epub ahead of print]

PMID:
29338314
3.

Aquaporin 4 blockade improves survival of murine heart allografts subjected to prolonged cold ischemia.

Ayasoufi K, Kohei N, Nicosia M, Fan R, Farr GW, McGuirk PR, Pelletier MF, Fairchild RL, Valujskikh A.

Am J Transplant. 2017 Dec 15. doi: 10.1111/ajt.14624. [Epub ahead of print]

PMID:
29243390
4.

New Answers to Old Conundrums: What Antibodies, Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report.

Dieudé M, West LJ, Muruve DA, Gunaratman L, Mohanakumar T, Zorn E, Cairo CW, Freed DH, Schultz KR, Fairchild RL, Hébert MJ.

Transplantation. 2018 Feb;102(2):209-214. doi: 10.1097/TP.0000000000001872.

5.

CD4+ T lymphocytes produce adiponectin in response to transplants.

Danturti S, Keslar KS, Steinhoff LR, Fan R, Dvorina N, Valujskikh A, Fairchild RL, Baldwin WM 3rd.

JCI Insight. 2017 Jun 15;2(12). pii: 89641. doi: 10.1172/jci.insight.89641. [Epub ahead of print]

6.

Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.

Chun N, Fairchild RL, Li Y, Liu J, Zhang M, Baldwin WM 3rd, Heeger PS.

Am J Transplant. 2017 Nov;17(11):2810-2819. doi: 10.1111/ajt.14328. Epub 2017 May 30.

PMID:
28444847
7.

Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.

Purroy C, Fairchild RL, Tanaka T, Baldwin WM 3rd, Manrique J, Madsen JC, Colvin RB, Alessandrini A, Blazar BR, Fribourg M, Donadei C, Maggiore U, Heeger PS, Cravedi P.

J Am Soc Nephrol. 2017 Aug;28(8):2377-2392. doi: 10.1681/ASN.2016101100. Epub 2017 Mar 16.

PMID:
28302753
8.

γδ T Cells Coexpressing Gut Homing α4β7 and αE Integrins Define a Novel Subset Promoting Intestinal Inflammation.

Do JS, Kim S, Keslar K, Jang E, Huang E, Fairchild RL, Pizarro TT, Min B.

J Immunol. 2017 Jan 15;198(2):908-915. doi: 10.4049/jimmunol.1601060. Epub 2016 Dec 7.

9.

Fingering a Natural Culprit During Antibody-Mediated Rejection.

Fairchild RL.

Transplantation. 2017 Apr;101(4):688-689. doi: 10.1097/TP.0000000000001597. No abstract available.

PMID:
27918373
10.

Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.

Gorbacheva V, Fan R, Fairchild RL, Baldwin WM 3rd, Valujskikh A.

J Am Soc Nephrol. 2016 Nov;27(11):3299-3307. Epub 2016 Mar 28.

11.

Turning on the Lights inside Neutrophils.

Fairchild RL.

J Immunol. 2016 Aug 1;197(3):681-2. doi: 10.4049/jimmunol.1600985. No abstract available.

12.

Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.

Kohei N, Tanaka T, Tanabe K, Masumori N, Dvorina N, Valujskikh A, Baldwin WM 3rd, Fairchild RL.

Kidney Int. 2016 Jun;89(6):1293-306. doi: 10.1016/j.kint.2016.02.030. Epub 2016 Apr 28.

13.

Juicing Tregs in situ to improve kidney allograft outcomes.

Fairchild RL.

Kidney Int. 2016 May;89(5):976-978. doi: 10.1016/j.kint.2016.01.020.

PMID:
27083272
14.

CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.

Ayasoufi K, Fan R, Fairchild RL, Valujskikh A.

J Immunol. 2016 Apr 1;196(7):3180-90. doi: 10.4049/jimmunol.1501435. Epub 2016 Feb 24.

15.

IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.

Iida S, Tsuda H, Tanaka T, Kish DD, Abe T, Su CA, Abe R, Tanabe K, Valujskikh A, Baldwin WM 3rd, Fairchild RL.

J Immunol. 2016 Mar 15;196(6):2827-37. doi: 10.4049/jimmunol.1500876. Epub 2016 Feb 8.

16.

Regulating T Cell Behavior.

Knechtle SJ, Fairchild RL.

Am J Transplant. 2016 Jul;16(7):1949-50. doi: 10.1111/ajt.13724. Epub 2016 Mar 17. No abstract available.

17.

Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.

Baldwin WM 3rd, Valujskikh A, Fairchild RL.

Curr Opin Organ Transplant. 2016 Feb;21(1):7-14. doi: 10.1097/MOT.0000000000000262. Review.

18.

Over-salting ruins the balance of the immune menu.

Min B, Fairchild RL.

J Clin Invest. 2015 Nov 2;125(11):4002-4. doi: 10.1172/JCI84690. Epub 2015 Oct 20.

19.

On the road, looking for signposts to tolerance: making progress or spinning wheels?

Feng S, Fairchild RL.

Am J Transplant. 2015 Nov;15(11):2793-4. doi: 10.1111/ajt.13481. Epub 2015 Oct 13. No abstract available.

20.

Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study.

Hricik DE, Augustine J, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Spain K, Iklé D, Bridges ND, Heeger PS; CTOT-01 consortium.

Am J Transplant. 2015 Dec;15(12):3166-73. doi: 10.1111/ajt.13401. Epub 2015 Jul 30.

21.

An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy.

Do JS, Visperas A, Sanogo YO, Bechtel JJ, Dvorina N, Kim S, Jang E, Stohlman SA, Shen B, Fairchild RL, Baldwin WM III, Vignali DA, Min B.

Mucosal Immunol. 2016 Jan;9(1):137-45. doi: 10.1038/mi.2015.45. Epub 2015 May 27.

22.

Urine CXCL10/IP-10 Fingers Ongoing Antibody-Mediated Kidney Graft Rejection.

Fairchild RL, Suthanthiran M.

J Am Soc Nephrol. 2015 Nov;26(11):2607-9. doi: 10.1681/ASN.2015040353. Epub 2015 May 6. No abstract available.

23.

Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW, Wiebe C, Tinckam K, Bunnapradist S, Samaniego-Picota M, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS; Clinical Trials in Organ Transplantation-09 Consortium.

J Am Soc Nephrol. 2015 Dec;26(12):3114-22. doi: 10.1681/ASN.2014121234. Epub 2015 Apr 29.

24.

Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model.

Abe T, Ishii D, Gorbacheva V, Kohei N, Tsuda H, Tanaka T, Dvorina N, Nonomura N, Takahara S, Valujskikh A, Baldwin WM 3rd, Fairchild RL.

Am J Transplant. 2015 May;15(5):1192-204. doi: 10.1111/ajt.13150. Epub 2015 Mar 2.

25.

Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants.

Kaul AM, Goparaju S, Dvorina N, Iida S, Keslar KS, de la Motte CA, Valujskikh A, Fairchild RL, Baldwin WM 3rd.

Am J Transplant. 2015 Feb;15(2):333-45. doi: 10.1111/ajt.13014. Epub 2015 Jan 12.

26.

IFN-γ production by memory helper T cells is required for CD40-independent alloantibody responses.

Gorbacheva V, Fan R, Wang X, Baldwin WM 3rd, Fairchild RL, Valujskikh A.

J Immunol. 2015 Feb 1;194(3):1347-56. doi: 10.4049/jimmunol.1401573. Epub 2014 Dec 29.

27.

Memory T Cells in Transplantation.

Su CA, Fairchild RL.

Curr Transplant Rep. 2014 Sep 1;1(3):137-146.

28.

Molecular monitoring of alloimmune-mediated injury in kidney transplant patients.

Traitanon O, Poggio ED, Fairchild RL.

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):625-30. doi: 10.1097/MNH.0000000000000064. Review.

PMID:
25202838
29.

Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.

Ishii D, Rosenblum JM, Nozaki T, Schenk AD, Setoguchi K, Su CA, Gorbacheva V, Baldwin WM 3rd, Valujskikh A, Fairchild RL.

J Immunol. 2014 Oct 1;193(7):3816-24. doi: 10.4049/jimmunol.1303256. Epub 2014 Aug 29.

30.

Experimental models of cardiac transplantation: design determines relevance.

Baldwin WM 3rd, Su CA, Shroka TM, Fairchild RL.

Curr Opin Organ Transplant. 2014 Oct;19(5):525-30. doi: 10.1097/MOT.0000000000000113. Review.

31.

Graft-derived CCL2 increases graft injury during antibody-mediated rejection of cardiac allografts.

Abe T, Su CA, Iida S, Baldwin WM 3rd, Nonomura N, Takahara S, Fairchild RL.

Am J Transplant. 2014 Aug;14(8):1753-64.

32.

Regulation of chemokine expression in the tumor microenvironment.

Gorbachev AV, Fairchild RL.

Crit Rev Immunol. 2014;34(2):103-20. Review.

PMID:
24940911
33.

IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.

Traitanon O, Gorbachev A, Bechtel JJ, Keslar KS, Baldwin WM 3rd, Poggio ED, Fairchild RL.

Am J Transplant. 2014 Jun;14(6):1277-89. doi: 10.1111/ajt.12719. Epub 2014 May 19.

34.

Endogenous memory CD8 T cells directly mediate cardiac allograft rejection.

Su CA, Iida S, Abe T, Fairchild RL.

Am J Transplant. 2014 Mar;14(3):568-79. doi: 10.1111/ajt.12605. Epub 2014 Feb 6.

35.

Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.

Gaughan A, Wang J, Pelletier RP, Nadasdy T, Brodsky S, Roy S, Lodder M, Bobek D, Mofatt-Bruce S, Fairchild RL, Henry ML, Hadley GA.

Am J Transplant. 2014 Feb;14(2):284-94. doi: 10.1111/ajt.12596. Epub 2014 Jan 10.

36.

Lessons and limits of mouse models.

Chong AS, Alegre ML, Miller ML, Fairchild RL.

Cold Spring Harb Perspect Med. 2013 Dec 1;3(12):a015495. doi: 10.1101/cshperspect.a015495. Review.

37.

Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.

Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Riggs M, Spain K, Ikle D, Bridges ND, Heeger PS; CTOT-01 consortium.

Am J Transplant. 2013 Oct;13(10):2634-44. doi: 10.1111/ajt.12426. Epub 2013 Aug 22.

38.

Endogenous memory CD8 T cells are activated within cardiac allografts without mediating rejection.

Setoguchi K, Hattori Y, Iida S, Baldwin WM 3rd, Fairchild RL.

Am J Transplant. 2013 Sep;13(9):2293-307. doi: 10.1111/ajt.12372. Epub 2013 Aug 5.

39.

Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection.

Iida S, Suzuki T, Tanabe K, Valujskikh A, Fairchild RL, Abe R.

Am J Transplant. 2013 Sep;13(9):2268-79. doi: 10.1111/ajt.12342. Epub 2013 Jul 8.

40.

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.

Suthanthiran M, Schwartz JE, Ding R, Abecassis M, Dadhania D, Samstein B, Knechtle SJ, Friedewald J, Becker YT, Sharma VK, Williams NM, Chang CS, Hoang C, Muthukumar T, August P, Keslar KS, Fairchild RL, Hricik DE, Heeger PS, Han L, Liu J, Riggs M, Ikle DN, Bridges ND, Shaked A; Clinical Trials in Organ Transplantation 04 (CTOT-04) Study Investigators.

N Engl J Med. 2013 Jul 4;369(1):20-31. doi: 10.1056/NEJMoa1215555.

41.

Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling.

Keslar KS, Lin M, Zmijewska AA, Sigdel TK, Tran TQ, Ma L, Bhasin M, Rao P, Ding R, Iklé DN, Mannon RB, Sarwal MM, Strom TB, Reed EF, Heeger PS, Suthanthiran M, Fairchild RL.

Am J Transplant. 2013 Jul;13(7):1891-7. doi: 10.1111/ajt.12284.

42.

Cutaneous tumors cease CXCL9/Mig production as a result of IFN-γ-mediated immunoediting.

Petro M, Kish D, Guryanova OA, Ilyinskaya G, Kondratova A, Fairchild RL, Gorbachev AV.

J Immunol. 2013 Jan 15;190(2):832-41. doi: 10.4049/jimmunol.1201906. Epub 2012 Dec 12.

43.

Molecular assassins from within: intracellular DAMPs from injured cells initiate tissue inflammation.

Fairchild RL, Bromberg JS.

Am J Transplant. 2012 Dec;12(12):3169. doi: 10.1111/ajt.12040. No abstract available.

44.

Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin.

Kish DD, Gorbachev AV, Parameswaran N, Gupta N, Fairchild RL.

J Immunol. 2012 Sep 1;189(5):2191-202. doi: 10.4049/jimmunol.1102729. Epub 2012 Jul 18.

45.

Unexpected role for MHC II-peptide complexes in shaping CD8 T-cell expansion and differentiation in vivo.

Do JS, Valujskikh A, Vignali DA, Fairchild RL, Min B.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12698-703. doi: 10.1073/pnas.1207219109. Epub 2012 Jul 16.

46.

Antibody-mediated rejection of single class I MHC-disparate cardiac allografts.

Hattori Y, Bucy RP, Kubota Y, Baldwin WM 3rd, Fairchild RL.

Am J Transplant. 2012 Aug;12(8):2017-28. doi: 10.1111/j.1600-6143.2012.04073.x. Epub 2012 May 11.

47.

The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients.

Sicard A, Phares TW, Yu H, Fan R, Baldwin WM 3rd, Fairchild RL, Valujskikh A.

Am J Transplant. 2012 Jul;12(7):1708-19. doi: 10.1111/j.1600-6143.2012.04009.x. Epub 2012 Mar 15.

48.

IL-1 receptor signaling is required at multiple stages of sensitization and elicitation of the contact hypersensitivity response.

Kish DD, Gorbachev AV, Fairchild RL.

J Immunol. 2012 Feb 15;188(4):1761-71. doi: 10.4049/jimmunol.1100928. Epub 2012 Jan 11.

49.

B cells in cardiac transplants: from clinical questions to experimental models.

Baldwin WM 3rd, Halushka MK, Valujskikh A, Fairchild RL.

Semin Immunol. 2012 Apr;24(2):122-30. doi: 10.1016/j.smim.2011.08.017. Epub 2011 Sep 19. Review.

50.

A TLR5 agonist inhibits acute renal ischemic failure.

Fukuzawa N, Petro M, Baldwin WM 3rd, Gudkov AV, Fairchild RL.

J Immunol. 2011 Oct 1;187(7):3831-9. doi: 10.4049/jimmunol.1003238. Epub 2011 Sep 2.

Supplemental Content

Loading ...
Support Center